Evaluating the Self-Care Efficacy and Needs of Cancer Patients Experiencing Chemotherapy Side Effects
Abstract
Background: Chemotherapy involves the strategic use of chemotherapeutic agents to manage cancer. While effective, it can harm healthy cells, leading to adverse effects. Our study aims to identify the self-care gaps faced by cancer patients and provide them with the essential knowledge, skills, and support to manage their condition effectively.
Methods: A cross-sectional descriptive-analytic design was employed, involving a purposive sample of 100 patients with cancer experiencing side effects from chemotherapy. A predesigned questionnaire evaluated the history of chemotherapy and its side effects, Psychological, social, and religious needs, and Level of independence in basic self-care and daily living skills. Descriptive and inferential statistics organized, tallied, and examined the gathered data.
Results: The majority 88 percent of clients meet their needs moderately adequate, only 9 percent of clients meet their needs adequately and 3 percent of clients cannot meet their needs. The overall mean score was 20.99 (SD = 4.802) out of a maximum possible score of 24, indicating that most patients demonstrated autonomy in self-care effectiveness concerning daily activities. A significant correlation was observed between the levels of independence and the demographic variables of the patients. Additionally, there is a noteworthy positive correlation (r = 0.303) between mental health, social, and spiritual requirements and the degree of independence in essential self-care efficacy among cancer patients.
Conclusion: The health team's primary duty is to raise awareness of and provide an explanation of self-care management of the disease. This will help people adopt a positive mindset and teach them how to practice at standard levels.
Keywords: Self-care efficacy; Cancer; Chemotherapy; Side effects; Patient needs
Full Text:
PDFReferences
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, (2018); 68(6): 394–424.
PDQ Supportive and Palliative Care Editorial Board. Family Caregivers in Cancer: Roles and Challenges (PDQ®). (2010); National Cancer Institute, USA. https://www.ncbi.nlm.nih.gov/books/NBK65845.2/
Williams PA. Fundamental Concepts and Skills for Nursing. (2028); Elsevier Health Sciences, London: 5th edition.
Godfrey CM, Harrison MB, Lysaght R, Lamb M, Graham ID, et al. Care of self–care by other–care of other: the meaning of self-care from research, practice, policy, and industry perspectives. International Journal of Evidence-Based Healthcare, (2011); 9(1): 3–24.
Smeltzer SC, Cheever KH, Bare B, Hinkle JL. Textbook of Medical-Surgical Nursing, Vol. 2. Wolters Kluwer Health, Philadelphia. (2011); PA, USA, 12th edition.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, (2015); 136: E359‑86.
Nandakumar A. Over 17 Lakh New Cancer Cases in India by 2020: ICMR. New Delhi, India: ICMR; 19 May, 2016. Available from: http://www.mid‑day.com/articles/Over 17lakhnewcancercasesinIndiaby2020‑icmr/17248152. [Last accessed on 2016 Oct 20].
Stewart BW, Wild CP. World Cancer Report 2014. London: IARC; 2014.
Saranath D, Khanna A. Current status of cancer burden: Global and Indian Scenario. Biomedical Research Journal, (2014); 1: 1‑5.
Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integrative Cancer Therapies, (2004); 3(4): 294-300.
Lee C, Longo VD. Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene, (2011); 30(30): 3305-16.
Chabner BA, Roberts TG Jr. Timeline: chemotherapy and the war on cancer. Nature Reviews Cancer, (2005); 5(1): 65-72.
Liu B, Ezeogu L, Zellmer L, Yu B, Xu N, et al. Protecting the normal to better kill the cancer. Cancer Medicine, (2015); 4(9): 1394-403.
Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, et al. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer, (2002); 95(1): 155-63.
Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, et al. On the receiving end--patient perception of the side-effects of cancer chemotherapy. European Journal of Cancer and Clinical Oncology, (1983); 19(2): 203-8.
Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, (1998); 16(5): 1689-96.
Berger AM. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncology Nursing Forum, (1998); 25(1): 51-62.
Sitzia J, Huggins L. Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer. Cancer Practice, (1998); 6(1): 13-21.
Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, et al. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. Journal of Pain and Symptom Management, (1999); 18(4): 233-42.
Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology, (2000); 18(4): 743-53.
Jacobsen PB, Stein K. Is fatigue a long-term side effect of breast cancer treatment?. Cancer Control, (1999); 6(3): 256-63.
Siddiqi A, Given CW, Given B, Sikorskii A. Quality of life among patients with primary, metastatic, and recurrent cancer. European Journal of Cancer Care, (2009); 18(1): 84–96.
Im EO, Lee B, Chee W. Shielded from the real world. Cancer Nursing, (2010); 33(3): E10–E20.
Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Research and Treatment, (2014); 46(2): 109–123.
Couzin-Frankel J. Dizzying Journey to a New Cancer Arsenal, American Association for the Advancement of Science, (2013); Washington, DC, USA.
Ust¨unda˘g S, Zencirci AD. Factors affecting the quality¨ of life of cancer patients undergoing chemotherapy: a questionnaire study. Asia-Pacific Journal of Oncology Nursing, (2015); 2(1): 17.
Wilkes G, Barton-Burke M. Oncology Nursing Drug Handbook. 2009.
Adenipekun A, Kupoluyi T, Soyannwo O. Knowledge and experience of cancer patients receiving chemotherapy in a teaching hospital in Nigeria. Internet Journal of Pain, Symptom Control and Palliative Care, (2012); 9(1): 1–5.
Aziz AW. Patient education: it’s the effect on the quality of life of a patient with cancer on chemotherapy. Journal of American Science, (2011); 7(8): 541-542.
Alteri R. Breast Cancer Facts & Figures, 2013. 2014, American Cancer Society, Atlanta, (2013); GA, USA.
Mahoney SE, Davis JM, Murphy EA, McClellan JL, Pena MM. Dietary quercetin reduces chemotherapy-induced fatigue in mice. Integrative Cancer Therapies, (2014); 13(5): 417–424.
Piamjariyakul U, Williams PD, Prapakorn S, Kim M, Park L, et.al. Cancer therapy-related symptoms and self-care in Thailand. European Journal of Oncology Nursing, (2010); 14(5): 387–394.
Alptekin S, G¨on¨ull¨u G, Y¨ucel I, Yarıs F. Characteristics and quality of life analysis of caregivers of cancer patients. Medical Oncology, (2010); 27(3): 607–617.
Janelsins MC, Devine KA, Mustian K, Mohile SG. Cognitive difficulties among patients with cancer receiving chemotherapy affect the quality of life: a University of Rochester Clinical Community Oncology Program study of 439 patients. Journal of Clinical Oncology, (2011); 29(15): 9119.
Gampenrieder SP, R. Bartsch, P. Matzneller, Pluschnig U, Dubsky P, et al. Capecitabine and vinorelbine as all-oral chemotherapy in HER2-negative locally advanced and metastatic breast cancer. Breast Care, (2010); 5(3): 158–162.
DOI: http://dx.doi.org/10.62940/als.v12i1.3350
Refbacks
- There are currently no refbacks.